FOXO4-DRI 10 mg vial
- Bulk Peptide Supply$57.50Listed price · deal not verifiedCOA tested Feb 12, 2026
- RUO$100Listed price · deal not verifiedCOA tested May 5, 2026
- Ion Peptides$119Listed price · deal not verifiedCOA tested Apr 3, 2026
FOXO4-DRI is a compound marketed around cellular aging or mitochondrial research.
Also known as fox-04 dri · fox04 · fox04-dri · foxo-4 · foxo4 · foxo4 dri
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
1 of 2 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: FOXO4-DRI COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $9.00 | $15.50 | 20 | 23 | |
| $9.00 | $15.50 | 19 | 21 | |
| $9.00 | $15.95 | 18 | 20 | |
| $9.95 | $17.10 | 8 | 9 |
What it is
PubChem identifies the record as Foxo4-dri. The listed molecular formula is C228H388N86O64. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
No registered human trial was identified under this exact name in the current review. Published work may be preclinical or indexed under another name.
Search indexed research for this compound ↗Market context
FOXO4-DRI is commonly sold or discussed for cellular aging, mitochondrial function, and longevity research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Polaris Peptides | Grade A- | 1 | 1 | $250 · 10 mg vialObserved Nov 14, 2026 |
| Ascension Peptides | Grade A- | 1 | 1 | $120 · 10 mg vialObserved Nov 14, 2026 |
| Evolve Peptides | Grade A- | 1 | 1 | $242.90 · 10 mg vialObserved Nov 14, 2026 |
| Orbitrex Peptides | Grade A- | 1 | 1 | $199.99 · 10 mg vialObserved Nov 14, 2026 |
| Southern Aminos | Grade A- | 1 | 1 | $71.50 · 10 mg vialEarlier observation Nov 2, 2026 |
| Bulk Peptide Supply | Grade B+ | 2 | 2 | $57.50 · 10 mg vialObserved Nov 14, 2026 |
| Glacier Aminos | Grade B+ | 1 | 1 | $134.99 · 10 mg vialObserved Nov 14, 2026 |
| Oasis Peptides | Grade B+ | 1 | 1 | $217.50 · 10 mg vialObserved Nov 14, 2026 |
| Oros Research | Grade B+ | 1 | 1 | $139.99 · 10 mg vialEarlier observation Oct 29, 2026 |
| Core Peptides | Grade B+ | 1 | 1 | $235 · 10 mg vialEarlier observation Oct 20, 2026 |
| Biolongevity Labs | Grade B | 1 | 0 | $274.97 · 10 mg vialObserved Nov 14, 2026 · out of stock |
| Coffee and Peppers | Grade B | 1 | 1 | $99.99 · 10 mg vialEarlier observation Oct 4, 2026 |
| Ion Peptides | Grade B | 1 | 1 | $119 · 10 mg vialObserved Nov 14, 2026 |
| RUO | Grade B | 1 | 1 | $100 · 10 mg vialObserved Nov 14, 2026 |
| NuLife Peptides | Grade B | 1 | 1 | $125 · 10 mg vialEarlier observation Oct 17, 2026 |
| Premier Bio Labs | Grade A- | 1 | 0 | $85 · 10 mg vialEarlier observation Sep 21, 2026 · out of stock |
| Royal Peptides | Grade B | 1 | 1 | $750 · 10 mg vial · pack of 10Observed Nov 14, 2026 |
| Nuscience Peptides | Not graded | 1 | 1 | $139.99 · 10 mg vialObserved Nov 14, 2026 |
| Pura Peptides | Not graded | 1 | 1 | $90 · 10 mg vialObserved Nov 14, 2026 |
11 tracked vendors list FOXO4-DRI without a current offer: Peptide Plugs (Grade A-), Peptide Crafters (Grade B+), RIVN Peptides (Grade B+), Simple Peptide (Grade B), Paramount Peptides (Grade B), Nationwide Peptides (Grade B+), Peptidology (Grade C), Atomik Labz (Not graded), Longevity Peptides (Not graded), Skye Peptides (Not graded), Tydes (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.